Skip to main content

Table 2 The prevalence of gastrointestinal disorders within the groups and compared using the odds ratios

From: Constipation in adults with neurofibromatosis type 1

  NF1 patients (n = 175) Controls (n = 91) Odds ratio, p, crude Odds ratio, p, adjusted for age and gender
Functional gastrointestinal disordera 33.1% (CI: 26.2–40.1) 14.3% (CI: 7.7–20,8) 2.97 (CI: 1.56–5.66), 0.001 3.06 (CI: 1.62–5.79), 0.001
Functional constipation 14.9% (CI: 9.6–20.1) 4.4% (CI: 0.02–8.6) 3.80 (CI: 1.27–11.31), 0.017 3.49 (CI: 1.14–10.64), 0.028
Irritable bowel syndrom 16.0% (CI: 10.6–21.4) 7.7% (CI: 0.03–12.9) 2.29 (CI: 0.98–5.33), 0.056 2.46 (CI: 1.10–5.47), 0.028
Functional dyspepsia 7.4% (CI: 3.5–11.3) 3.3% (CI: 0–6.9) 2.35 (CI: 0.67–8.32), 0.184 2.25 (CI: 0.70–7.17), 0.170
  1. NF1 neurofibromatosis type 1, CI 95% Confidence Interval, p p-value
  2. aAny of the three; functional dyspepsia, IBS or functional constipation
  3. Legend: The prevalence reported within the group of patients with NF1 and the control group and compared using the odds ratio